CIK 0001388320 · Non-accelerated filer<br>Smaller reporting company
Actinium Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ATNM
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 880378336
- Phone
- (646) 677-3870
- Business address
- 100 PARK AVE., 23RD FLOOR, NEW YORK, NY, 10017
- Former names
- Cactus Ventures, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-14 | David Matthew T Chief Financial Officer | Grant or award | +250,000 | 250,000 | ||
| 2026-10-14 | David Matthew T Chief Financial Officer | Grant or award · Stock Option (right to purchase) | +250,000 | 250,000 | ||
| 2026-09-02 | Nicholson, C. David Director | Grant or award | +62,800 | 63,300 | ||
| 2026-09-02 | Nicholson, C. David Director | Grant or award · Stock Option (Right to Buy) | +94,200 | 94,200 | ||
| 2026-09-02 | Shetty Ajit Director | Grant or award | +61,600 | 62,357 | ||
| 2026-09-02 | Shetty Ajit Director | Grant or award · Stock Option (Right to Buy) | +92,400 | 92,400 | ||
| 2026-09-02 | Almenoff June Sherie Director | Grant or award 10b5-1 | +18,000 | 18,000 | ||
| 2026-09-02 | Almenoff June Sherie Director | Grant or award · Stock Option (Right to Buy) 10b5-1 | +27,000 | 27,000 | ||
| 2026-09-02 | SETH SANDESH Chief Executive Officer | Grant or award | +753,600 | 938,081 | ||
| 2026-09-02 | SETH SANDESH Chief Executive Officer | Grant or award | +1,027,274 | 1,965,355 | ||
| 2026-09-02 | SETH SANDESH Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +1,130,400 | 1,130,400 | ||
| 2026-09-02 | Steinhart Richard I Director | Grant or award | +62,800 | 63,116 | ||
| 2026-09-02 | Steinhart Richard I Director | Grant or award · Stock Option (Right to Buy) | +94,200 | 94,200 | ||
| 2026-09-02 | Chell Jeffrey W. Director | Grant or award | +61,600 | 61,600 | ||
| 2026-09-02 | Chell Jeffrey W. Director | Grant or award · Stock Option (Right to Buy) | +92,400 | 92,400 | ||
| 2025-08-18 | SETH SANDESH Chief Executive Officer | Shares withheld for taxes | −120,900 | $1.71 | $207K | 184,481 |
| 2025-03-31 | Steinhart Richard I Director | Returned to the company · Stock Option (Right to Buy) | −2,500 | 0 | ||
| 2025-03-31 | Steinhart Richard I Director | Returned to the company · Stock Option (Right to Buy) | −2,500 | 0 | ||
| 2025-03-31 | Steinhart Richard I Director | Returned to the company · Stock Option (Right to Buy) | −2,500 | 0 | ||
| 2025-03-31 | Steinhart Richard I Director | Returned to the company · Stock Option (Right to Buy) | −8,333 | 0 |
Page 1 of 16 · 316 trades